Literature DB >> 15737727

What's good for the host is good for the bug.

JoAnne L Flynn1, John Chan.   

Abstract

Tuberculosis, caused by Mycobacterium tuberculosis, kills approximately two million people each year. The infection is characterized by an inflammatory response culminating in the formation of a granuloma, a collection of immune cells that controls the infection. However, the granuloma can be the source of immunopathology that encourages transmission. Recent data support the idea that mycobacterial products can positively and negatively regulate the inflammatory response. Our contention is that induction of the immune response and subsequent granuloma formation is beneficial to the host for control of infection, and is also beneficial to the bacillus, as a place to hide and as a means for transmitting the infection to naive hosts.

Entities:  

Mesh:

Year:  2005        PMID: 15737727     DOI: 10.1016/j.tim.2005.01.005

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  60 in total

1.  Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice.

Authors:  Michela Sali; Gabriele Di Sante; Alessandro Cascioferro; Antonella Zumbo; Chiara Nicolò; Valentina Donà; Stefano Rocca; Annabella Procoli; Matteo Morandi; Francesco Ria; Giorgio Palù; Giovanni Fadda; Riccardo Manganelli; Giovanni Delogu
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

2.  Macrophage polarization drives granuloma outcome during Mycobacterium tuberculosis infection.

Authors:  Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; JoAnne L Flynn; Denise E Kirschner
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

3.  Mycobacterium tuberculosis lineage--what's in your lungs?

Authors:  Midori Kato-Maeda; Payam Nahid
Journal:  Clin Infect Dis       Date:  2012-01-15       Impact factor: 9.079

4.  Noncognate Mycobacterium tuberculosis toxin-antitoxins can physically and functionally interact.

Authors:  Ling Zhu; Jared D Sharp; Hiroshi Kobayashi; Nancy A Woychik; Masayori Inouye
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

Review 5.  Insights into early mycobacterial pathogenesis from the zebrafish.

Authors:  Robin Lesley; Lalita Ramakrishnan
Journal:  Curr Opin Microbiol       Date:  2008-06-19       Impact factor: 7.934

Review 6.  The role of B cells and humoral immunity in Mycobacterium tuberculosis infection.

Authors:  John Chan; Simren Mehta; Sushma Bharrhan; Yong Chen; Jacqueline M Achkar; Arturo Casadevall; JoAnne Flynn
Journal:  Semin Immunol       Date:  2014-10-28       Impact factor: 11.130

7.  Characterization of a secretory hydrolase from Mycobacterium tuberculosis sheds critical insight into host lipid utilization by M. tuberculosis.

Authors:  Khundrakpam Herojit Singh; Bhavya Jha; Abhisek Dwivedy; Eira Choudhary; Arpitha G N; Anam Ashraf; Divya Arora; Nisheeth Agarwal; Bichitra Kumar Biswal
Journal:  J Biol Chem       Date:  2017-05-17       Impact factor: 5.157

Review 8.  IDO-expressing regulatory dendritic cells in cancer and chronic infection.

Authors:  Alexey Popov; Joachim L Schultze
Journal:  J Mol Med (Berl)       Date:  2007-09-18       Impact factor: 4.599

9.  Association of Mycobacterium tuberculosis PE PGRS33 polymorphism with clinical and epidemiological characteristics.

Authors:  Sarah Talarico; M Donald Cave; Betsy Foxman; Carl F Marrs; Lixin Zhang; Joseph H Bates; Zhenhua Yang
Journal:  Tuberculosis (Edinb)       Date:  2007-05-01       Impact factor: 3.131

Review 10.  Novel adjunctive therapies for the treatment of tuberculosis.

Authors:  A A Ordonez; M Maiga; S Gupta; E A Weinstein; W R Bishai; S K Jain
Journal:  Curr Mol Med       Date:  2014-03       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.